alexa Personalised Dosing of Hyperthermia | OMICS International| Abstract

ISSN: 2476-2253

Journal of Cancer Diagnosis

  • Research Article   
  • J Cancer Diagn 2016, Vol 1(2): 107
  • DOI: 10.4172/2476-2253.1000107

Personalised Dosing of Hyperthermia

Gyula Peter Szigeti1, Oliver Szasz2* and Gabriella Hegyi3
1Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Hungary
2Department of Biotechnics, Szent Istvan University, Hungary
3Department of Complementary Medicine, Medical School, University of Pecs, Hungary
*Corresponding Author : Oliver Szasz, Department of Biotechnics, Szent Istvan University, Hungary, Tel: +36-23-555-510, Fax: +36-23-555-515, Email: [email protected]

Received Date: Sep 19, 2016 / Accepted Date: Oct 27, 2016 / Published Date: Oct 31, 2016


Objective: Our objective is to show the superiority of the membrane selection and connected energy dose fixed via personal sensing.

Method: Hyperthermia in oncology involves heating malignant cells and causing thermal damage in an attempt to destroy them. This could be immediate (necrotic) cell-distortion and ignite natural cell elimination, like apoptosis or autophagy.

Two concepts determine the dose of hyperthermia: (1) isothermal tumour heating, homogeneous tumour temperature, which is used for necrosis based cumulative equivalent minutes (CEM), and (2) inhomogeneous heating of the tumour following the heterogeneity of the lesion itself. The personalized dosing used by oncothermia is heterogenic, it selects the membrane rafts of malignant cells that sense temperature on a cellular level targeting the nano-clusters of transmembrane proteins. The method uses the standard specific energy dosing controlled by personal sensing of the treated patient maintaining homeostatic control through gradual step-up heating process.

Results: The nano excitation is thermal (fits to Arrhenius plot), and acts directly on the membrane of malignant cells. The homeostatic physiology reactions do not suppress the effective hyperthermia action with this heating. The stress reactions could be more regulated, the vasocontraction and vasodilatation effects roughly compensate each other. This allows a clear measurability of the dose of the treatment: instead of the temperature based cumulative equivalent minutes (CEM) it uses absorbed energy controlled by the RF-circuit. Due to the small mass of targets the applied power is low, the energy-sink surface cooling is fixed to homeostasis ensuring the accuracy of the energydose and improving the safety of the hyperthermia method.

Conclusion: The nanoselection of malignant cells via oncothermia allows us to return to the dosing “gold standard,” which is also applied in radiotherapy. This energy-based dose is personalised with accurate step-up heating taking the wash-out time and the personal sensing of the patient into account.

Keywords: Hperthermia; Oncothermia; Dose; Personalisation; Heat sensing; Step-up heating; Homeostasis; Fight-or-flight reaction

Citation: Szigeti GP, Szasz O, Hegyi G (2016) Personalised Dosing of Hyperthermia. J Cancer Diagn 1:107. Doi: 10.4172/2476-2253.1000107

Copyright: © 2016 Szigeti GP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment
Share This Article
Article Usage
  • Total views: 1211
  • [From(publication date): 0-2016 - Mar 24, 2018]
  • Breakdown by view type
  • HTML page views: 1105
  • PDF downloads: 106